Page last updated: 2024-08-23

swainsonine and cyclin d1

swainsonine has been researched along with cyclin d1 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dou, K; Gong, Z; Ji, R; Liu, W; Tao, K; Wang, T; Wang, X; You, N	1

Other Studies

1 other study(ies) available for swainsonine and cyclin d1

Article	Year
Swainsonine inhibits growth and potentiates the cytotoxic effect of paclitaxel in hepatocellular carcinoma in vitro and in vivo. Oncology reports, 2012, Volume: 28, Issue:6 Topics: Antineoplastic Agents; Apoptosis; Astragalus propinquus; bcl-2 Homologous Antagonist-Killer Protein; bcl-2-Associated X Protein; Carcinoma, Hepatocellular; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Cyclin E; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Drug Synergism; Fas Ligand Protein; fas Receptor; Hep G2 Cells; Humans; Liver Neoplasms; NF-kappa B; Paclitaxel; Swainsonine	2012

Article

Year

Swainsonine inhibits growth and potentiates the cytotoxic effect of paclitaxel in hepatocellular carcinoma in vitro and in vivo.

Oncology reports, 2012, Volume: 28, Issue:6

Topics: Antineoplastic Agents; Apoptosis; Astragalus propinquus; bcl-2 Homologous Antagonist-Killer Protein; bcl-2-Associated X Protein; Carcinoma, Hepatocellular; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Cyclin E; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Drug Synergism; Fas Ligand Protein; fas Receptor; Hep G2 Cells; Humans; Liver Neoplasms; NF-kappa B; Paclitaxel; Swainsonine

2012